Urgent.News

What's breaking now, across thousands of outlets.

World

Johnson & Johnson looking to buy Ollin Biosciences for up to US$3.4bil

NEW YORK: Johnson & Johnson is poised to buy privately held eye disease drug developer Ollin Biosciences for up to US$3.4 billion, the Financial Times reported on Sunday, citing people familiar with the matter.

Johnson & Johnson looking to buy Ollin Biosciences for up to US$3.4bil

We haven't written up this one. New Straits Times has the full story — the link below goes straight to it.

Read the original at nst.com.my →

More in World

More from Monday 16 November →